| Dr Thomas Clifford Davis, MD | |
|
407 S Medical Arts Ct Ste C, Gillette, WY 82716-3372 | |
| (307) 689-4318 | |
| Not Available |
| Full Name | Dr Thomas Clifford Davis |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 25 Years |
| Location | 407 S Medical Arts Ct Ste C, Gillette, Wyoming |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336139120 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 7762A (Wyoming) | Primary |
| Entity Name | Davis Ent Specialists, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124323480 PECOS PAC ID: 0648451906 Enrollment ID: O20110221000655 |
News Archive
Ronald A. Katz Technology Licensing, L.P. announced today that PMSI Holdings Corporation, one of the world's largest pharmaceutical services companies serving the United States with headquarters in Tampa, FL, has entered into an agreement to purchase rights under the patent portfolio held by Ronald A. Katz Technology Licensing, L.P. and licensed through its affiliate, A2D, L.P.
Children exposed to high levels of polybrominated diphenyl ethers either prenatally or during childhood have poorer attention, fine motor coordination, and intelligence quotients than those exposed to low levels, show results from two studies.
Bathing tumor-ridden livers in chemotherapy increases the length of time certain cancer patients survive without progression of the disease, according to Phase III trial results being presented at the 3rd annual Symposium on Clinical Interventional Oncology (CIO), in collaboration with the International Symposium on Endovascular Therapy (ISET).
Teva Pharmaceutical Industries Ltd. announced today that the U.S. District Court for the Southern District of Indiana has issued a decision invalidating two patents listed in the FDA's Orange Book for Eli Lilly's Evista® (raloxifene hydrochloride) Tablets in litigation concerning Teva's abbreviated new drug application to market a generic version. The court found these patents to be invalid for lack of written description.
Staying away from those with contagious infections, no matter how lonely it gets, may not only be common sense, but a natural instinct. But that doesn't mean humans or animals will automatically fall in line.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas Clifford Davis, MD 407 S Medical Arts Ct Ste C, Gillette, WY 82716-3372 Ph: (307) 689-4318 | Dr Thomas Clifford Davis, MD 407 S Medical Arts Ct Ste C, Gillette, WY 82716-3372 Ph: (307) 689-4318 |
News Archive
Ronald A. Katz Technology Licensing, L.P. announced today that PMSI Holdings Corporation, one of the world's largest pharmaceutical services companies serving the United States with headquarters in Tampa, FL, has entered into an agreement to purchase rights under the patent portfolio held by Ronald A. Katz Technology Licensing, L.P. and licensed through its affiliate, A2D, L.P.
Children exposed to high levels of polybrominated diphenyl ethers either prenatally or during childhood have poorer attention, fine motor coordination, and intelligence quotients than those exposed to low levels, show results from two studies.
Bathing tumor-ridden livers in chemotherapy increases the length of time certain cancer patients survive without progression of the disease, according to Phase III trial results being presented at the 3rd annual Symposium on Clinical Interventional Oncology (CIO), in collaboration with the International Symposium on Endovascular Therapy (ISET).
Teva Pharmaceutical Industries Ltd. announced today that the U.S. District Court for the Southern District of Indiana has issued a decision invalidating two patents listed in the FDA's Orange Book for Eli Lilly's Evista® (raloxifene hydrochloride) Tablets in litigation concerning Teva's abbreviated new drug application to market a generic version. The court found these patents to be invalid for lack of written description.
Staying away from those with contagious infections, no matter how lonely it gets, may not only be common sense, but a natural instinct. But that doesn't mean humans or animals will automatically fall in line.
› Verified 2 days ago
Dr. Ryan Duane Black, D.O. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 501 S Burma Ave, Gillette, WY 82716 Phone: 307-688-0110 Fax: 307-688-0111 | |
Dr. Ian R Swift, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 407 S Medical Arts Ct, Suite F, Gillette, WY 82716 Phone: 307-688-4368 |